CD4 and acute myeloid leukemia: After chemotherapy, the fraction of CD3+CD4+ T cells was much higher than that before chemotherapy (BM and PB, both p < 0.001), and there were significant differences between AML patients and HDs (BM, p = 0.011; PB, HDs vs. AML‐T1, p < 0.001).